Elevation Oncology, Inc. (ELEV)
Latest ELEV Insider Trades
About Elevation Oncology, Inc. (ELEV)
Elevation Oncology, Inc. files with the SEC under CIK 0001783032 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
90-Day SEC Filing Activity
No Form 4 activity for ELEV in the last 90 days.
ELEV Insider Transactions (Form 4)
4111 Form 4 filings on record, the earliest from Nov 19, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Timothy P. Clackson | Other | Common Stock | 47,330 | $0.36 |
ELEV Insider Trading - FAQ
What is the latest insider trade for ELEV?
Elevation Oncology, Inc. (ELEV) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-07-23. The full record for ELEV runs to 11 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ELEV stock?
No insider purchases of ELEV were filed in the last 90 days.
How many insiders are selling ELEV stock?
No insider sales of ELEV were filed in the last 90 days.
Where can I see ELEV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ELEV Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ELEV insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ELEV to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Timothy P. Clackson view on EDGAR
- - Steve Elms view on EDGAR
- - R. Michael Carruthers view on EDGAR
- - Julie M. Cherrington view on EDGAR
- - Darcy Mootz view on EDGAR
- - Alan B. Sandler view on EDGAR
- - Tammy Furlong view on EDGAR
- - Steve Elms view on EDGAR
- - Timothy P. Clackson view on EDGAR
- - Joseph J. Ferra Jr. view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ELEV's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ELEV insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
